Warner Chilcott to Pay $125 Million in False Claims Act Case
Warner Chilcott U.S. Sales, a subsidiary of pharmaceutical maker Warner Chilcott, today reached a $125 million settlement with the Department of Justice to resolve charges of healthcare fraud. The company pleaded guilty to criminal charges that the company paid kickbacks to physicians throughout the United States to induce them to ...
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
Article
When the Department of Justice goes too far
In a rare face-off, the Department of Justice and corporate defense attorneys debate the limits of federal criminal law and prosecution. Jaclyn Jaeger reports.
-
ArticleFormer ADM execs inflated operating profits, SEC alleges
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.
-
OpinionNational Fraud Enforcement Division: A dangerous escalation of compliance risk
Chief compliance officers and general counsel, beware: The Trump administration’s merging of its whole-of-government enforcement approach with its political agenda forewarns of escalating compliance risk on a national scale.